文献速递脊柱外科骨质疏松与代谢性骨病

活动性类风湿关节炎与脊柱侧凸:一项中期队列研究

Active Rheumatoid Arthritis and Scoliosis: A Mid-Term Cohort Study.
PubMed 文献 · Spine (Phila Pa 1976) · 2024-05-15

回顾性纳入180例类风湿关节炎患者并按疾病活动度分为缓解组76例与未缓解组104例。随访期间53例(29.4%)脊柱侧凸进展,未缓解组年进展率1.04°/年高于缓解组0.59°/年(P=0.001)。基线Cobb角≥10°、使用糖皮质激素及基线未缓解是脊柱侧凸进展的显著危险因素。

要点

  • 未缓解组脊柱侧凸年进展率1.04°/年,高于缓解组0.59°/年(P=0.001)。
  • 基线Cobb角≥10°的OR为3.14,使用糖皮质激素的OR为2.88,基线未缓解的OR为2.83。
  • 两组新发椎体骨折的发生率无差异。

核心结论

  • 类风湿关节炎疾病活动度与患者脊柱侧凸进展相关。
  • 基线脊柱侧凸≥10°、需糖皮质激素治疗且基线未缓解的类风湿关节炎患者可能为脊柱侧凸进展的高危人群。

研究设计与样本

  • 回顾性队列研究,纳入180例随访超过2年且均行站立位脊柱X线检查的类风湿关节炎患者。
  • 按基于红细胞沉降率的疾病活动度评分-28分为缓解组76例与未缓解组104例,评估C7中心骶骨垂直线、骨盆倾斜、主弯Cobb角及弯曲位置等影像学指标。

主要发现

  • 平均随访4.8年期间,53例(29.4%)患者出现脊柱侧凸进展。
  • 未缓解组基线及末次随访时Cobb角大于缓解组。
  • 未缓解组脊柱侧凸年进展率为1.04°/年,缓解组为0.59°/年(P=0.001)。
  • 两组新发椎体骨折的发生率无差异。
  • 基线Cobb角≥10°(OR:3.14;95%CI:1.38-7.13;P=0.006)、使用糖皮质激素(OR:2.88;95%CI:1.18-7.06;P=0.021)及基线未缓解(OR:2.83;95%CI:1.25-6.41;P=0.012)为脊柱侧凸进展的显著危险因素。

关键数值与推荐

  • 基线Cobb角≥10°者脊柱侧凸进展的OR为3.14(95%CI:1.38-7.13;P=0.006)。
  • 使用糖皮质激素者脊柱侧凸进展的OR为2.88(95%CI:1.18-7.06;P=0.021)。
  • 基线未缓解者脊柱侧凸进展的OR为2.83(95%CI:1.25-6.41;P=0.012)。
  • 证据等级为Level III。

临床怎么用

  • 作者认为,基线脊柱侧凸≥10°、需糖皮质激素治疗且基线未缓解的类风湿关节炎患者可能为脊柱侧凸进展的高危人群。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Retrospective cohort study. OBJECTIVE: To elucidate the factors related to the progression of scoliosis in patients with rheumatoid arthritis (RA) using longitudinal cohort data. BACKGROUND: Of patients, 30% with RA have lumbar scoliosis. However, the effectiveness of current treatment methods in preventing the progression of scoliosis is not well understood due to a lack of longitudinal studies. PATIENTS AND METHODS: We enrolled 180 patients with RA who were followed up for over 2 years, all of whom underwent standing spinal x-rays. These patients were categorized based on their disease activity score-28 with erythrocyte sedimentation rate into 2 groups: (1) those in remission (n = 76) and (2) those in nonremission (n = 104). We evaluated various radiographic measures, including C7 center sacral vertical line, pelvic obliquity, major Cobb angle, and curve location. RESULTS: Fifty-three (29.4%) patients presented progression of scoliosis during a mean follow-up period of 4.8 years. Patients in the nonremission showed larger Cobb angle at baseline and final follow-up, compared with those in remission. The annual progression rate of the curve was also greater in the nonremission group (1.04°/yr) than in the remission group (0.59°/yr, P = 0.001). There was no difference in the incidence of new vertebral fractures. The presence of a baseline Cobb angle of 10° or more [odds ratio (OR): 3.14; 95% CI: 1.38-7.13; P = 0.006], glucocorticoid use (OR: 2.88; 95% CI: 1.18-7.06; P = 0.021), and nonremission at baseline (OR: 2.83; 95% CI: 1.25-6.41; P = 0.012) were significant risk factors for progression of scoliosis. CONCLUSION: RA disease activity is linked to the progression of scoliosis in patients with RA. Patients with RA who present with initial scoliosis of ≥10°, require glucocorticoids for treatment and are in nonremission at baseline may be at high risk for scoliosis progression. LEVEL OF EVIDENCE: Level III.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Honda S, Murata K, Otsuki B, et al. Active Rheumatoid Arthritis and Scoliosis: A Mid-Term Cohort Study. Spine (Phila Pa 1976). 2024. PMID: 38747218. doi:10.1097/BRS.0000000000005035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。